Show all postsFiltered by: Cameron A. Mingay

Cameron Mingay Discusses Potential Marijuana Supply Crunch with Bloomberg

With the legalization of recreational marijuana in Canada slated to occur within the next 12 months, a looming concern is whether Canada's supply will meet its demand. In a recent Bloomberg article, Cameron Mingay discusses practical realities associated with ramping up legal marijuana production in Canada.

Read Full Article
Disclosure Requirements for Non-Venture Issuers Regarding Women in Board and Executive Officer Positions – A Review

On June 7, 2017, the Canadian news cycle addressed cannabis industry insider criticism at the dearth of women on boards and in senior management positions at Canadian cannabis companies, with reports suggesting that 5% of board seats at publicly traded marijuana producers are occupied by women.

Read Full Article
Draft Cannabis Act Released by Canadian Federal Government

Today the federal government released Bill C-45, the draft Cannabis Act. If enacted, this will make Canada the first G7 country to legalize recreational cannabis. Cannabis will remain illegal as the bill moves through the legislative process. If it is approved by Parliament, the bill could become law with a target date of no later than July 2018, according to the Government of Canada.

Read Full Article
March 2017 Deal Round-Up

The following is a selection of major deals in the life science space that closed or were announced as closed in March 2017.

Read Full Article
February 2017 Deal Round-Up

The following is a selection of major deals in the life science space that closed or were announced as closed in February 2017.

Read Full Article
January 2017 Deal Round-Up

The following is a summary of major deals in the life science space that closed or were announced as closed in January 2017. Vancouver-based Quark Venture Inc., through its Global Health Sciences Venture Fund, continued to be an active investor, with investments made both in Canada and the United States in the month of January 2017.

Read Full Article
Key Takeaways from the 2017 Cantech Investment Conference

On January 18, 2017, investors, analysts, and entrepreneurs converged on the Metro Toronto Convention Centre for the 2017 Cantech Investment Conference. Exhibitors at the conference spanned a number of industries from cybersecurity to specialty finance to cannabis.

Read Full Article
The Academies Release Major Report on Cannabis and Cannabis-derived Products

The National Academies of Sciences, Engineering, and Medicine has released a major US government-funded report entitled "The Health Effects of Cannabis and Cannabinoids: The Current States of Evidence and Recommendations for Research" (the "Report") outlining benefits and harms associated with cannabis on a range of public health and safety issues. Cannabis scientific and medical research has historically been impeded because of its illegality, stigma, and related challenges, so the report represents a major positive step towards providing guidance and evidence-based research for physicians, researchers, and patients alike.

Read Full Article
Cameron Mingay Discusses Divesting for Growth

In the pharmaceutical and biotechnology industry, strategic acquisitions and consolidation are often pointed to as the prevailing trends. However, divestment of non-core business units has become an important tool to drive strategic growth across all industries, including in the life sciences sector.

Read Full Article
December 2016 Deal Round-Up

The following is a summary of major deals in the life science space that closed or were announced in December 2016. 

Read Full Article
Deciphering the Term Sheet: Valuation

This article is the first in a series of articles that will delve into the most important terms in investment Term Sheets for early-stage companies.

Read Full Article
November 2016 Deal Round-Up

The following is a summary of major deals in the life science space that closed or were announced as closed in November 2016. 

Read Full Article
Tips for First-Time Investment Fundraisers

The first time a venture seeks external fundraising, often from an angel investor or venture capital firm, is a major milestone. The following suggests some tactical tools for reaching out to, and getting the attention and interest of, these investors:

Read Full Article
October 2016 Deal Round-Up

A monthly round-up of a selection of major Canadian deals in the life sciences and healthcare sector.

Read Full Article
New US$500 Million Global Life Sciences Venture Fund Launched

Quark Venture Inc., a Canadian based venture firm, and GF Securities Company Limited, a China based investment bank, have recently launched a US$500 million life sciences venture capital fund. The fund will be based out of Vancouver, and is expected to focus on building a diversified portfolio of innovative biotechnology, pharmaceutical, and life sciences companies. It is now the largest life science fund in Canada and has already committed US$100 million into various life sciences companies.

Read Full Article
Developing Toronto's Life Science and Healthcare Innovation Economy

The core theme of the 2016 World Economic Forum in Davos, Switzerland was the arrival of the Fourth Industrial Revolution, with its velocity, scope and disruptive impact on almost every industry of every country.1  Much of the change is attributable to the creation and duplication of the digital universe of data, believed to be expanding by 40% per year.2  One of the sectors which is expected to be radically altered, and benefit significantly, is life sciences, and particularly, healthcare.

Read Full Article
The Capital Landscape for Early-Stage Life Science Ventures

As an early-stage start-up, regardless of industry, understanding the players in the investment landscape is important. Over the past several years, the types of investors interested in early-stage life science ventures has diversified, with investors that would normally invest at later stages now often looking to fund companies at earlier stages of commercialization.1  The following is a cross-section of the key players.

Read Full Article
The Growth of the Cannabis Industry

Over the past decade, cannabis distribution in North America has evolved from a criminal offense to – well, still a criminal offense – but also a billion dollar legal industry. The lines are often blurred as the cannabis industry undergoes a major regulatory and legal overhaul. As an emerging industry, we have seen, and will continue to see, an increasing number of opportunities for the development and growth of cannabis companies in both Canada and the United States. The development of cannabis in the areas of life sciences and medicine has been accompanied by an expansion of the recreational market.

Read Full Article
A Case that Could Determine the Future of Health Care in Canada

On September 6, 2016, the British Columbia Supreme Court began hearing a case (“Cambie”) that could have far-reaching effects on the face of health care in Canada.

Read Full Article